SeaLife Pharma pursues a novel strategy in the identification of active substances to speed-up the discovery and development of new products. Instead of indiscriminate screening of a multitude of organisms, we attempt to identify promising candidates through characters in their biology and ecology without damaging marine ecosystems. This new “bio-logical” screening approach, termed “Ecotargeting”, focuses on organisms under conditions of physiological stress, heavy competition or predator and pathogen pressure.
Ecotargeting – the new approach to identify targets more efficiently
SeaLife Pharma’s Ecotargeting is a new method to systematically identify future drug candidates more efficiently and effectively than by conventional random collection.
